ID: h-e128d575e8
Hypothesis

Perturbation-first validation should precede therapeutic claims for VEGF Family GWAS Signals and Cerebrovascular-Neuronal Coupling in AD Hippocampus

The debate supports treating this as a validation program before ranking it as a therapy.
🧬 VEGF-🩺 neurodegeneration🎯 Composite 61%💱 $0.55▼9.1%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 1 support 1 oppose
✓ All Quality Gates Passed

🧪 Overview

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.

🧬 Mechanism

🔗 Mechanism from KG for VEGF-

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    VEGF_family_genes["VEGF family genes"] -->|associated with| Alzheimer_s_disease_endop["Alzheimer's disease endophenotypes"]
    VEGF_variants["VEGF variants"] -->|regulates| hippocampal_vascular_neur["hippocampal vascular-neuronal coupling"]
    VEGF_family_genetic_contr["VEGF-family genetic control"] -->|modulates| vascular_neuronal_couplin["vascular-neuronal coupling in vulnerable hippocampal regions"]
    VEGF["VEGF"] -->|risk factor for| Alzheimer_s_disease["Alzheimer's disease"]
    vascular_changes["vascular changes"] -->|associated with| neurodegeneration["neurodegeneration"]
    sess_a7f528aa_20c4_409d_a["sess_a7f528aa-20c4-409d-a8c3-e2662850e63d_task_66f1207e_recon"] -->|causal extracted| processed["processed"]
    style VEGF_family_genes fill:#ce93d8,stroke:#333,color:#000
    style Alzheimer_s_disease_endop fill:#4fc3f7,stroke:#333,color:#000
    style VEGF_variants fill:#ce93d8,stroke:#333,color:#000
    style hippocampal_vascular_neur fill:#4fc3f7,stroke:#333,color:#000
    style VEGF_family_genetic_contr fill:#4fc3f7,stroke:#333,color:#000
    style vascular_neuronal_couplin fill:#4fc3f7,stroke:#333,color:#000
    style VEGF fill:#ce93d8,stroke:#333,color:#000
    style Alzheimer_s_disease fill:#ef5350,stroke:#333,color:#000
    style vascular_changes fill:#4fc3f7,stroke:#333,color:#000
    style neurodegeneration fill:#4fc3f7,stroke:#333,color:#000
    style sess_a7f528aa_20c4_409d_a fill:#4fc3f7,stroke:#333,color:#000
    style processed fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix1 supports1 contradicts
Supports
The proposed priority experiment is concrete: spatial transcriptomics plus vascular imaging ordered against amyloid and tau burden across hippocampal subfields
Contradicts
Therapeutic tractability is not established by the current source evidence.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — VEGF-

No curated PDB or AlphaFold mapping for VEGF- yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for VEGF- →

No DepMap CRISPR Chronos data found for VEGF-.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.6%
Volatility
Low
0.0017
Events (7d)
3
Price History
▼9.1%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.